Evaluation of safety and efficacy of azithromycin in lower respiratory tract infections (LRTI)
Artículo
en Inglés
| IMSEAR
| ID: sea-66618
ABSTRACT
Azithromycin was given to 55 cases of lower respiratory tract infections in the doses of 500 mg on day 1, followed by 250 mg on days 2-5. It produced bacteriological cure in 70.8% patients and clinical cure or improvement in 69.09% of patients. 4.27% of patients had throat colonisation with new organisms, of which 9.09% needed a second antibiotic. The drug was well tolerated and minor side effects were noted. Gastrointestinal disturbances (16.36%) headache and giddiness (14.55%), rash (3.64%) were the noted side effects. Reduction of platelet count by 50% occurred in 12.29% of the cases compared to 0.2% reported earlier. But this thrombocytopenia was clinically not significant, as it did not cause any symptoms.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Infecciones del Sistema Respiratorio
/
Femenino
/
Humanos
/
Masculino
/
Adolescente
/
Resultado del Tratamiento
/
Azitromicina
/
Estudios de Evaluación como Asunto
/
India
/
Antibacterianos
Tipo de estudio:
Estudio diagnóstico
/
Estudios de evaluación
País/Región como asunto:
Asia
Idioma:
Inglés
Año:
1996
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS